Illustration of Texas A&M's vessel-on-a-chip replicating blood vessel branches, aneurysms, and stenosis for studying flow effects on cells.
Illustration of Texas A&M's vessel-on-a-chip replicating blood vessel branches, aneurysms, and stenosis for studying flow effects on cells.
Billede genereret af AI

Texas A&M researchers build customizable living vessel-on-a-chip to mimic branching, aneurysms and stenosis

Billede genereret af AI
Faktatjekket

Researchers at Texas A&M University say they have developed a customizable “vessel-chip” that recreates the complex shapes of human blood vessels—including branches, aneurysm-like bulges and stenosis-like narrowings—so scientists can study how altered blood flow affects endothelial cells and evaluate potential treatments without relying on animal models.

Human blood vessels are not uniform tubes: they bend, branch, narrow and widen in ways that change blood flow and are linked to where vascular disease can develop. Researchers in the Department of Biomedical Engineering at Texas A&M University have reported a microfluidic “vessel-chip” platform designed to reproduce that architectural complexity.

The device is a small-scale vessel-on-a-chip system lined with endothelial cells—the cells that form the inner lining of blood vessels—so the team can examine how flow patterns translate into differences in shear stress and endothelial responses. Jennifer D. Lee, identified by Texas A&M as a biomedical engineering master’s student working in the lab of Abhishek Jain, described the motivation as capturing how branching, aneurysm-like expansions and stenosis-like restrictions can substantially alter flow patterns and the stresses experienced by vessel walls.

According to the university’s release, the project builds on earlier work in the same group by Tanmay Mathur, described as a former graduate student who developed a straight vessel-chip design. The paper lists Lee, Ankit Kumar, Mathur and Jain as authors and was published in Lab on a Chip as “Vascular architecture-on-chip: engineering complex blood vessels for reproducing physiological and heterogeneous hemodynamics and endothelial function” (2025, volume 25, issue 11, pages 2620–2631; DOI: 10.1039/D4LC00968A).

Jain, whom Texas A&M describes as an associate professor and the Barbara and Ralph Cox ’53 faculty fellow in biomedical engineering, said the new approach makes it possible to create more complex, living vessel structures and study disease-relevant sites that may be difficult to reproduce with simpler models.

Texas A&M said Lee began the work as an undergraduate honors student seeking hands-on research experience and continued through the university’s Master of Science fast-track program. The release also quoted Lee describing the lab environment as helping her develop collaboration and communication skills.

The team said future iterations may add cell types beyond endothelial cells to study interactions between flowing blood and surrounding tissues—an effort Jain described as progressing toward what he called a “fourth dimensionality” in organs-on-a-chip research.

In the university’s account, the project received support from multiple organizations, including the U.S. Army Medical Research Program, NASA, the Biomedical Advanced Research and Development Authority, the National Institutes of Health, the U.S. Food and Drug Administration, the National Science Foundation, and Texas A&M’s Office of Innovation Translational Investment Funds.

Researchers said the vessel-chip platform could support patient-tailored studies of blood flow and treatment response, offering a non-animal system for evaluating potential therapies and studying vascular disease mechanisms.

Hvad folk siger

Discussions on X about the Texas A&M vessel-on-a-chip are sparse and recent, primarily consisting of neutral to positive shares and paraphrases of the article by science enthusiasts and news accounts, with no evident negative or skeptical sentiments.

Relaterede artikler

Lab-grown spinal cord organoid model showing injury repair: inflammation and scarring on one side, reduced scars and nerve regrowth after experimental 'dancing molecules' therapy on the other.
Billede genereret af AI

Lab-grown human spinal cord organoids show signs of repair after simulated injury, Northwestern study reports

Rapporteret af AI Billede genereret af AI Faktatjekket

Northwestern University researchers say they developed an advanced lab-grown human spinal cord organoid model that reproduces key features of traumatic injury—such as inflammation and glial scarring—and that an experimental “dancing molecules” therapy reduced scar-like tissue and promoted nerve-fiber growth in the model.

Researchers have created a detailed brain organoid mimicking the developing cerebral cortex, complete with blood vessels that closely resemble those in a real brain. This advance addresses a key limitation in lab-grown mini-brains, potentially allowing them to survive longer and provide deeper insights into neurological conditions. The organoid, grown from human stem cells, features evenly distributed vessels with hollow centers, marking a significant step forward in brain research.

Rapporteret af AI

Researchers have developed a non-invasive imaging tool called fast-RSOM that visualizes the body's smallest blood vessels through the skin. This technology identifies early microvascular endothelial dysfunction, a precursor to cardiovascular disease, allowing for earlier interventions. The portable device could integrate into routine checkups to improve heart health outcomes.

Researchers at Lund University in Sweden have created a cell-free cartilage scaffold that guides the body to repair damaged bone. The innovation, tested successfully in animal models, avoids strong immune reactions and offers a universal alternative to patient-specific grafts. Plans are underway to test it in human clinical trials.

Rapporteret af AI

Chinese scientists have drawn inspiration from the Japanese paper-cutting art of kirigami to develop stretchable microelectrode arrays, aiming to overcome limitations in electrode technology such as that used by Neuralink. These arrays were implanted into macaque monkeys, where they flexed with brain tissue to record hundreds of neurons simultaneously. The research was published in the February 5 issue of Nature Electronics.

A billionaire-backed biotech startup, R3 Bio, is developing genetically engineered 'organ sacks'—whole organ systems without a brain—as an alternative to animal testing. This idea comes as the Trump administration phases out animal experimentation across the federal government. A cofounder states the long-term goal is to create human versions.

Dette websted bruger cookies

Vi bruger cookies til analyse for at forbedre vores side. Læs vores privatlivspolitik for mere information.
Afvis